Table 1 Distribution of clinical characteristics and treatment received overall, and among women diagnosed with screen-detected, interval and symptomatic breast cancers (n = 1,760)
From: Factors associated with wait times across the breast cancer treatment pathway in Ontario
Overall | Screen-detected | Interval | Symptomatic | |
|---|---|---|---|---|
N = 1,760 | N = 1096 | N = 309 | N = 355 | |
Characteristics | N (%) | N (%) | N (%) | N (%) |
Age Category | ||||
50-59 | 680 (38.6) | 415 (37.9) | 124 (40.1) | 141 (39.7) |
60-69 | 1080 (61.4) | 681(62.1) | 185 (59.9) | 214 (60.3) |
Diagnosis Year * | ||||
1995-1999 | 974 (55.3) | 602 (54.9) | 147 (47.6) | 225 (63.4) |
2000-2003 | 786 (44.7) | 494 (45.1) | 162 (52.4) | 130 (36.6) |
Chemotherapy † | ||||
No chemotherapy | 1098 (62.4) | 728 (66.4) | 177 (57.3) | 193 (62.8) |
Chemotherapy | 662 (37.6) | 368(33.6) | 132 (42.7) | 162 (37.2) |
Radiotherapy a‡ | ||||
No Radiotherapy | 370 (21.2) | 218 (19.9) | 58 (18.8) | 94 (26.5) |
Radiotherapy | 1377 (78.8) | 873 (79.7) | 246 (79.6) | 258 (72.7) |
Definite Surgery b δ | ||||
Incisional/excisional | 112 (6.6) | 79 (7.5) | 14 (4.7) | 19 (5.8) |
Partial Mastectomy | 1071 (63.4) | 688 (64.8) | 185 (62.0) | 198 (60.0) |
Total Mastectomy | 101 (6.0) | 55 (5.2) | 24 (8.1) | 22 (6.7) |
Modified/Radical Mast. | 328 (19.4) | 185 (17.4) | 59 (19.8) | 84 (25.5) |
ALND/SLNB | 77 (4.6) | 54 (5.1) | 16 (5.4) | 7 (2.1) |
TNM Stage ** | ||||
1 | 925 (52.6) | 662 (60.4) | 161 (52.1) | 102 (28.7) |
2 | 603 (34.3) | 332 (30.3) | 97 (31.4) | 174 (49.0) |
3 | 232 (13.2) | 102 (9.3) | 51 (16.5) | 79 (22.3) |